ADAMA (000553) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
3 Dec, 2025Executive summary
2024 was a challenging year for the crop protection industry, with persistent overcapacity, price pressure, and cautious channel purchasing behavior globally.
Despite an 11% year-over-year sales decline to $4.1 billion, EBITDA grew 15% to $469 million, driven by cost management, product mix improvement, and the Fight Forward transformation program.
Gross margin improved to 25.6% from 22.7% in 2023, reflecting better cost control and a focus on higher-margin products.
Net losses narrowed by 13% to $206 million, with adjusted net losses reflecting even greater improvement after excluding one-time items.
Free cash flow reached up to $270 million, supported by significant inventory reduction and disciplined capital allocation.
Financial highlights
Q4 2024 sales were $1.1 billion, down 2% year-over-year, but up 2% at constant exchange rates (CER).
Q4 gross profit rose 14% and EBITDA surged 45% to $137 million, with gross margin at 25.2% and EBITDA margin at 12.3%.
Full-year sales declined 11%, mainly due to 8% lower prices and flat volumes; gross profit held steady at $1.06 billion.
Operating cash flow improved by $172 million to $528 million, and inventory days dropped to 177.
OPEX reduced by $68 million for FY 2024, reflecting cost discipline.
Outlook and guidance
No formal 2025 guidance was provided, but management expressed confidence in continued momentum from operational improvements and the Fight Forward program.
The company expects further benefits from ongoing cost discipline, portfolio optimization, and structural transformation.
Channel inventory levels are easing, but pricing pressure persists due to overcapacity and softening crop commodity prices.
Latest events from ADAMA
- Net profit rebounded to RMB 432.6 million as margins improved despite revenue decline.000553
Q2 2026 - Q1 2026 sales and net profit rose, while EBITDA declined amid higher costs and price pressures.000553
Q1 2026 - EBITDA rose 25% in 2025 despite a 2% sales drop, with strong cash flow and improved margins.000553
Q4 2025 - Sales and margins improved, with net loss narrowing and operational efficiency gains achieved.000553
Q3 2025 - Q2 2025 saw sales growth, margin expansion, and positive adjusted net income amid price pressure.000553
Q2 2025 - Margins and cash flow improved in Q3 2024 despite lower sales and ongoing pricing pressure.000553
Q3 2024 - Sales fell 16% in H1 2024, but margins and cash flow improved through cost discipline.000553
Q2 2024 - Net profit rebounded and EBITDA rose 21% as margins and cash flow improved despite lower sales.000553
Q1 2025